MCKESSON CORPORATION had the largest decline in reported obligations
$213.6M→$173.9M−$39.7M
The contractor now ranks #1 by positive obligations and accounts for 95.9% of positive obligations, based on 3,670 reported actions.
Federal Capture Intelligence
Pharmaceutical Preparation Manufacturing contractors at the Department of Justice
Contract actions: October 1, 2021 – July 27, 2026
Updated July 28, 2026 Department of Justice agency guide
NAICS 325412 · Pharmaceutical Preparation Manufacturing
- Latest 12 months
- $181.3M
- Net obligations · Down $36.6M vs. $217.9M preceding
- Prime contractors
- 36
- With positive obligations in the latest 12 months
Market snapshot for Pharmaceutical Preparation Manufacturing at the Department of Justice
Federal records show $933.8M in net obligations across 10,193 awards in Pharmaceutical Preparation Manufacturing at the Department of Justice from Oct 1, 2021 through Jul 27, 2026. This market accounts for 2.3% of $41.4B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 16.8% from $217.9M to $181.3M. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.
FY26 year-to-date: $150.5M versus $186.5M through the same date in FY25 (−19.3%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $149.2M | 3,992 | Complete |
| FY2023 | $188.7M | 4,269 | Complete |
| FY2024 | $228.2M | 4,844 | Complete |
| FY2025 | $217.2M | 4,292 | Complete |
| FY2026 | $150.5M | 3,267 | YTD through Jul 27, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $933.8M
- 10,193 awards · 74 prime contractors
- Latest 12-month movement
- −16.8%
- $181.3M vs. $217.9M
- Leading eight prime share
- 98.8%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 2.3% of $41.4B in agency-wide net obligations.
- Set-aside share when reported
- 1.6% of 1,224 awards with reported set-aside status.
- Set-aside reporting
- 19 set aside · 1,205 no set-aside · 8,969 not reported
What changed in the last 12 months?
Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.
Competitive shifts
Buyer demand
Reported obligations through FCC POLLOCK decreased
$22.5M→$16.1M−$6.4M
Latest-period activity spans 119 awards across 1 prime contractor.
Reported obligations through FMC FORT WORTH increased
$5.6M→$8.1M+$2.5M
Latest-period activity spans 45 awards across 8 prime contractors.
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Funding pattern for Pharmaceutical Preparation Manufacturing at the Department of Justice
See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.
18.1% of positive obligations were attributed to FMC BUTNER. That represents $32.8M, down $916K from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- FMC BUTNER18.1% · $32.8M · down $916K
- FCC POLLOCK8.9% · $16.1M · down $6.4M
- FMC FORT WORTH4.5% · $8.1M · up $2.5M
- USMCFP SPRINGFIELD4.3% · $7.9M · up $1.1M
- FMC CARSWELL3.5% · $6.4M · up $467K
- All other reported offices60.7% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
FMC BUTNER
#1Rank unchangedLatest 12 months
$32.8M
18.1% of positive obligations
Versus preceding 12 months
−$916K
11 active prime contractors · 33 awards
View office comparison and evidence
Reported obligations decreased 2.7% from $33.7M to $32.8M. The office’s share of positive obligations moved from 15.5% to 18.1%, a change of +2.6 percentage points.
The latest period contains 70 actions across 33 awards and 4 newly active prime contractors. The preceding period contained 10 active prime contractors and 51 awards.
Reported funding office
FCC POLLOCK
#2Rank unchangedLatest 12 months
$16.1M
8.9% of positive obligations
Versus preceding 12 months
−$6.4M
1 active prime contractor · 119 awards
View office comparison and evidence
Reported obligations decreased 28.6% from $22.5M to $16.1M. The office’s share of positive obligations moved from 10.3% to 8.9%, a change of −1.5 percentage points.
The latest period contains 141 actions across 119 awards. The preceding period contained 1 active prime contractor and 131 awards.
Leading award-level changes
- MCKESSON CORPORATION · PIID 15B51925F00000144−$12.9M: $12.9M → $0
- MCKESSON CORPORATION · PIID 15B51925F00000177+$4.9M: $0 → $4.9M
Reported funding office
FMC FORT WORTH
#3Up 6 from #9Latest 12 months
$8.1M
4.5% of positive obligations
Versus preceding 12 months
+$2.5M
8 active prime contractors · 45 awards
View office comparison and evidence
Reported obligations increased 44.3% from $5.6M to $8.1M. The office’s share of positive obligations moved from 2.6% to 4.5%, a change of +1.9 percentage points.
The latest period contains 57 actions across 45 awards and 3 newly active prime contractors. The preceding period contained 6 active prime contractors and 39 awards.
Leading award-level changes
- MCKESSON CORPORATION · PIID 15B50926F00000006+$4.5M: $0 → $4.5M
- TAKEDA PHARMACEUTICALS AMERICA, INC. · PIID 15B50926F00000076+$549K: $0 → $549K
Reported funding office
USMCFP SPRINGFIELD
#4Up 2 from #6Latest 12 months
$7.9M
4.3% of positive obligations
Versus preceding 12 months
+$1.1M
6 active prime contractors · 64 awards
View office comparison and evidence
Reported obligations increased 16.2% from $6.8M to $7.9M. The office’s share of positive obligations moved from 3.1% to 4.3%, a change of +1.2 percentage points.
The latest period contains 111 actions across 64 awards and 2 newly active prime contractors. The preceding period contained 4 active prime contractors and 57 awards.
Reported funding office
FMC CARSWELL
#5Up 3 from #8Latest 12 months
$6.4M
3.5% of positive obligations
Versus preceding 12 months
+$467K
11 active prime contractors · 57 awards
View office comparison and evidence
Reported obligations increased 7.9% from $5.9M to $6.4M. The office’s share of positive obligations moved from 2.7% to 3.5%, a change of +0.8 percentage points.
The latest period contains 91 actions across 57 awards and 6 newly active prime contractors. The preceding period contained 6 active prime contractors and 33 awards.
Reported funding office
FMC LEXINGTON
#6Down 2 from #4Latest 12 months
$6.3M
3.5% of positive obligations
Versus preceding 12 months
−$2.4M
3 active prime contractors · 46 awards
View office comparison and evidence
Reported obligations decreased 27.5% from $8.6M to $6.3M. The office’s share of positive obligations moved from 4.0% to 3.5%, a change of −0.5 percentage points.
The latest period contains 79 actions across 46 awards and 2 newly active prime contractors. The preceding period contained 3 active prime contractors and 45 awards.
Reported funding office
FCC COLEMAN
#7Down 4 from #3Latest 12 months
$6.1M
3.4% of positive obligations
Versus preceding 12 months
−$3.1M
2 active prime contractors · 36 awards
View office comparison and evidence
Reported obligations decreased 33.3% from $9.2M to $6.1M. The office’s share of positive obligations moved from 4.2% to 3.4%, a change of −0.8 percentage points.
The latest period contains 65 actions across 36 awards. The preceding period contained 5 active prime contractors and 37 awards.
Reported funding office
USP TERRE HAUTE
#8Up 3 from #11Latest 12 months
$6.0M
3.3% of positive obligations
Versus preceding 12 months
+$1.3M
4 active prime contractors · 34 awards
View office comparison and evidence
Reported obligations increased 27.9% from $4.7M to $6.0M. The office’s share of positive obligations moved from 2.1% to 3.3%, a change of +1.1 percentage points.
The latest period contains 58 actions across 34 awards and 2 newly active prime contractors. The preceding period contained 2 active prime contractors and 28 awards.
Reported funding office
FMC DEVENS
#9Down 4 from #5Latest 12 months
$5.5M
3.0% of positive obligations
Versus preceding 12 months
−$1.4M
6 active prime contractors · 23 awards
View office comparison and evidence
Reported obligations decreased 20.4% from $6.9M to $5.5M. The office’s share of positive obligations moved from 3.2% to 3.0%, a change of −0.1 percentage points.
The latest period contains 40 actions across 23 awards and 3 newly active prime contractors. The preceding period contained 3 active prime contractors and 10 awards.
Reported funding office
FMC ROCHESTER
#10Up 3 from #13Latest 12 months
$4.3M
2.4% of positive obligations
Versus preceding 12 months
+$923K
3 active prime contractors · 45 awards
View office comparison and evidence
Reported obligations increased 27.2% from $3.4M to $4.3M. The office’s share of positive obligations moved from 1.6% to 2.4%, a change of +0.8 percentage points.
The latest period contains 84 actions across 45 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 35 awards.
Reported funding office
USP HAZELTON
#12Down 5 from #7Latest 12 months
$2.9M
1.6% of positive obligations
Versus preceding 12 months
−$3.0M
3 active prime contractors · 33 awards
View office comparison and evidence
Reported obligations decreased 50.9% from $6.0M to $2.9M. The office’s share of positive obligations moved from 2.8% to 1.6%, a change of −1.1 percentage points.
The latest period contains 53 actions across 33 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 32 awards.
Reported funding office
FCI BASTROP
#30Up 46 from #76Latest 12 months
$1.4M
0.80% of positive obligations
Versus preceding 12 months
+$970K
2 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations increased 204.9% from $473K to $1.4M. The office’s share of positive obligations moved from 0.22% to 0.80%, a change of +0.6 percentage points.
The latest period contains 33 actions across 14 awards. The preceding period contained 2 active prime contractors and 21 awards.
Reported funding office
FCI WILLIAMSBURG
#55Down 37 from #18Latest 12 months
$898K
0.50% of positive obligations
Versus preceding 12 months
−$1.8M
3 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations decreased 66.6% from $2.7M to $898K. The office’s share of positive obligations moved from 1.2% to 0.50%, a change of −0.7 percentage points.
The latest period contains 30 actions across 15 awards and 2 newly active prime contractors. The preceding period contained 2 active prime contractors and 48 awards.
How this work is bought
Reported award structure, competition, pricing, work categories, and contracting channels for Pharmaceutical Preparation Manufacturing at the Department of Justice.
During Jul 28, 2025–Jul 27, 2026, this market recorded $185.2M in positive net award obligations across 1,956 awards. The leading reported procedure, Negotiated Proposal/Quote, accounted for 95.8% of that positive-obligation base. Awards with a reported parent IDV accounted for 98.0%.
- Leading award type
- 97.8%
- Delivery Order
- Leading reported procedure
- 95.8%
- Negotiated Proposal/Quote
- Reported parent IDV
- 98.0%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 323 of 1,956 awards reported offers · Limited reporting
Same-NAICS comparison
Compared with the NAICS 325412 peer median, parent-IDV obligation share is 13.5 percentage points higher, reported full-and-open obligation share is 44.2 percentage points higher, delivery-order obligation share is 16.3 percentage points higher, and median positive award obligations are 79.8% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 98.0% | 84.5% | +13.5 pts |
| Reported full-and-open obligation share | 97.7% | 53.5% | +44.2 pts |
| Delivery-order obligation share | 97.8% | 81.5% | +16.3 pts |
| Median positive award obligations | $12K | $60K | -79.8% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Defense (DOD)
- Department of Health and Human Services (HHS)
- Department of Veterans Affairs (VA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 1,717 | $181.1M | 97.8% |
| Purchase Order(B) | 229 | $3.7M | 2.0% |
| BPA Call(A) | 10 | $461K | 0.25% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 1,633 | $177.5M | 95.8% |
| FSS(C) | 84 | $3.6M | 1.9% |
| BPA(E) | 10 | $461K | 0.25% |
| Not reported | 229 | $3.7M | 2.0% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 1,643 | $177.9M | 96.1% |
| Multiple Award(M) | 84 | $3.6M | 1.9% |
| Not reported | 229 | $3.7M | 2.0% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 1,636 | $177.4M | 95.8% |
| Simplified Acquisition(SP1) | 219 | $3.7M | 2.0% |
| Subject To Multiple Award Fair Opportunity(MAFO) | 84 | $3.6M | 1.9% |
| Only One Source(SSS) | 17 | $549K | 0.30% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full And Open Competition(A) | 1,720 | $181.0M | 97.7% |
| Competed Under SAP(F) | 151 | $2.9M | 1.6% |
| Not Competed Under SAP(G) | 68 | $802K | 0.43% |
| Not Competed(C) | 17 | $549K | 0.30% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 37 | $2.6M | 1.4% |
| Fair Opportunity Given(FAIR) | 47 | $1.0M | 0.56% |
| Not reported | 1,872 | $181.6M | 98.0% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SAP Non-Competition (FAR 13)(SP2) | 31 | $709K | 0.38% |
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 16 | $501K | 0.27% |
| Less Than Or Equal To The Micro-Purchase Threshold(MPT) | 37 | $93K | 0.050% |
| Urgency (FAR 6.302-2)(URG) | 1 | $48K | 0.030% |
| Not reported | 1,871 | $183.9M | 99.3% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 1,956 | $185.2M | 100.0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs And Biologicals(6505) | 1,790 | $177.9M | 96.0% |
| Pharmacy Services(Q517) | 81 | $3.0M | 1.6% |
| Medical And Surgical Instruments, Equipment, And Supplies(6515) | 41 | $1.7M | 0.92% |
| Medical- Managed Healthcare(Q201) | 15 | $1.3M | 0.70% |
| Chemical And Pharmaceutical Products Manufacturing Machinery(3650) | 7 | $874K | 0.47% |
| Food, Oils And Fats(8945) | 1 | $208K | 0.11% |
| Other reported values | 21 | $216K | 0.12% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Federal Prison System / Bureau of Prisons(1540) | 1,944 | $184.6M | 99.7% |
| Federal Bureau of Investigation(1549) | 4 | $333K | 0.18% |
| Drug Enforcement Administration(1524) | 7 | $171K | 0.090% |
| U.S. Marshals Service(1544) | 1 | $82K | 0.040% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Fmc Butner(15B106) | 31 | $33.0M | 17.8% |
| Fcc Pollock(15B519) | 105 | $16.1M | 8.7% |
| Fmc Fort Worth(15B509) | 42 | $8.1M | 4.4% |
| Usmcfp Springfield(15B414) | 54 | $7.9M | 4.3% |
| Fcc Coleman(15B302) | 27 | $6.7M | 3.6% |
| Fmc Lexington(15B109) | 35 | $6.6M | 3.5% |
| Other reported values | 1,662 | $106.8M | 57.7% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36W79720D0001(3600) | 1,483 | $176.5M | 95.3% |
| V797D50492(3600) | 9 | $1.8M | 0.95% |
| 36F79724D0159(3600) | 20 | $813K | 0.44% |
| VA797P12D0001(3600) | 4 | $460K | 0.25% |
| 36F79720D0237(3600) | 18 | $333K | 0.18% |
| 36F79718D0403(3600) | 12 | $270K | 0.15% |
| 36E79726D0009(3600) | 89 | $229K | 0.12% |
| 15F06722A0000207(1549) | 1 | $200K | 0.11% |
| Other reported values | 91 | $975K | 0.53% |
| Not reported | 229 | $3.7M | 2.0% |
Exactly matched vehicle usage
$42K · 0.020%
7 awards matched an unambiguous catalog vehicle PIID. Company membership is not used as evidence of award-channel usage.
Offers, award size, and timing
- Median reported offers
- 1 median
- 323 reported · 1,633 not reported · Limited reporting
- Positive award obligations
- $12K median
- $2K–$72K middle 50%
- Reported performance period
- 30 days median
- 1,946 reported · 10 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Prime contractors for Pharmaceutical Preparation Manufacturing at the Department of Justice
Latest 12-month concentration and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 36prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 95.9%of positive obligations in the last 12 months
- Leading four prime contractors
- 98.0%of positive obligations in the last 12 months
- Leading eight prime contractors
- 98.8%of positive obligations in the last 12 months
Based on $181.3M in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
15 leading contractors
- #1
Last 12mo obligations
$173.9M
95.9%
Dollar movement
−$39.7M
vs. prior 12 months
Last 12mo awards
1,990 awards
3,670 actions
Historical and award details for MCKESSON CORPORATION
- Obligations: prior → latest
- $213.6M → $173.9M
- −18.6%
- Share: prior → latest
- 98.0% → 95.9%
- −2.1 percentage points
- All-period obligations
- $908.1M
- 97.2% of all-period positive obligations · 9,051 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 209 221 Not reported 1,781 1,946 Reported small business 0 4 All-period set-aside types
- 1 · Total small business
- #2
Last 12mo obligations
$1.8M
0.97%
Dollar movement
+$703K
vs. prior 12 months
Last 12mo awards
9 awards
12 actions
Historical and award details for TAKEDA PHARMACEUTICALS AMERICA, INC.
- Obligations: prior → latest
- $1.1M → $1.8M
- +66.8%
- Share: prior → latest
- 0.48% → 0.97%
- +0.5 percentage points
- All-period obligations
- $5.9M
- 0.64% of all-period positive obligations · 45 awards
- Recorded activity
- Since Oct 27, 2021
- through Mar 19, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 9 11 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$1.1M
0.61%
Dollar movement
+$560K
vs. prior 12 months
Last 12mo awards
24 awards
34 actions
Historical and award details for PRIORITY HEALTHCARE DISTRIBUTION INC
- Obligations: prior → latest
- $542K → $1.1M
- +103.4%
- Share: prior → latest
- 0.25% → 0.61%
- +0.4 percentage points
- All-period obligations
- $2.2M
- 0.23% of all-period positive obligations · 56 awards
- Recorded activity
- Since Feb 9, 2022
- through Jul 15, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 3 Reported no set-aside 24 12 Not reported 0 0 Reported small business 5 12 All-period set-aside types
- 9 · Total small business
- #4
Last 12mo obligations
$813K
0.45%
Dollar movement
+$154K
vs. prior 12 months
Last 12mo awards
20 awards
23 actions
Historical and award details for ACTELION PHARMACEUTICALS US, INC.
- Obligations: prior → latest
- $659K → $813K
- +23.4%
- Share: prior → latest
- 0.30% → 0.45%
- +0.1 percentage points
- All-period obligations
- $2.4M
- 0.26% of all-period positive obligations · 66 awards
- Recorded activity
- Since Feb 13, 2023
- through Jul 15, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 20 19 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$438K
0.24%
Dollar movement
+$450K
vs. prior 12 months
Last 12mo awards
96 awards
105 actions
Historical and award details for SANOFI VACCINES US INC.
- Obligations: prior → latest
- −$13K → $438K
- Not comparable
- Share: prior → latest
- 0% → 0.24%
- +0.2 percentage points
- All-period obligations
- $2.8M
- 0.30% of all-period positive obligations · 222 awards
- Recorded activity
- Since Mar 22, 2022
- through Jul 7, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 3 Not reported 94 12 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$385K
0.21%
Dollar movement
+$129K
vs. prior 12 months
Last 12mo awards
2 awards
8 actions
Historical and award details for PETNET SOLUTIONS, INC.
- Obligations: prior → latest
- $256K → $385K
- +50.3%
- Share: prior → latest
- 0.12% → 0.21%
- +0.1 percentage points
- All-period obligations
- $948K
- 0.10% of all-period positive obligations · 6 awards
- Recorded activity
- Since Oct 5, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 2 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$352K
0.19%
Dollar movement
+$134K
vs. prior 12 months
Last 12mo awards
4 awards
4 actions
Historical and award details for BIOLOGICS, INC.
- Obligations: prior → latest
- $219K → $352K
- +61.3%
- Share: prior → latest
- 0.10% → 0.19%
- +0.1 percentage points
- All-period obligations
- $571K
- 0.060% of all-period positive obligations · 14 awards
- Recorded activity
- Since Sep 17, 2024
- through Apr 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 10 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$333K
0.18%
Dollar movement
+$333K
vs. prior 12 months
Last 12mo awards
18 awards
20 actions
Historical and award details for BAYER HEALTHCARE PHARMACEUTICALS INC
- Obligations: prior → latest
- $0 → $333K
- Not comparable
- Share: prior → latest
- 0% → 0.18%
- +0.2 percentage points
- All-period obligations
- $345K
- 0.040% of all-period positive obligations · 19 awards
- Recorded activity
- Since Apr 24, 2024
- through Jun 3, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 18 0 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$317K
0.17%
Dollar movement
+$317K
vs. prior 12 months
Last 12mo awards
3 awards
4 actions
Historical and award details for COVERMYMEDS PHARMACY LLC
- Obligations: prior → latest
- $0 → $317K
- Not comparable
- Share: prior → latest
- 0% → 0.17%
- +0.2 percentage points
- All-period obligations
- $317K
- 0.030% of all-period positive obligations · 3 awards
- Recorded activity
- Since Feb 9, 2026
- through Jun 10, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 0 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$270K
0.15%
Dollar movement
+$270K
vs. prior 12 months
Last 12mo awards
12 awards
14 actions
Historical and award details for DAIICHI SANKYO, INC
- Obligations: prior → latest
- $0 → $270K
- Not comparable
- Share: prior → latest
- 0% → 0.15%
- +0.1 percentage points
- All-period obligations
- $270K
- 0.030% of all-period positive obligations · 12 awards
- Recorded activity
- Since Oct 28, 2025
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 12 0 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$265K
0.15%
Dollar movement
+$236K
vs. prior 12 months
Last 12mo awards
4 awards
4 actions
Historical and award details for ASD SPECIALTY HEALTHCARE, LLC
- Obligations: prior → latest
- $29K → $265K
- +800.0%
- Share: prior → latest
- 0.010% → 0.15%
- +0.1 percentage points
- All-period obligations
- $295K
- 0.030% of all-period positive obligations · 5 awards
- Recorded activity
- Since Jul 3, 2025
- through Jan 12, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$175K
0.10%
Dollar movement
+$144K
vs. prior 12 months
Last 12mo awards
10 awards
12 actions
Historical and award details for DIASOL INC
- Obligations: prior → latest
- $31K → $175K
- +468.3%
- Share: prior → latest
- 0.010% → 0.10%
- +0.1 percentage points
- All-period obligations
- $206K
- 0.020% of all-period positive obligations · 12 awards
- Recorded activity
- Since Jul 2, 2025
- through Jul 7, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 10 2 Reported small business 10 2 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$127K
0.070%
Dollar movement
+$127K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for NATIONWIDE PHARMACEUTICAL LLC
- Obligations: prior → latest
- $0 → $127K
- Not comparable
- Share: prior → latest
- 0% → 0.070%
- +0.1 percentage points
- All-period obligations
- $127K
- 0.010% of all-period positive obligations · 1 award
- Recorded activity
- Since Jul 28, 2025
- through Jul 28, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 0 Reported small business 1 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$115K
0.060%
Dollar movement
+$115K
vs. prior 12 months
Last 12mo awards
7 awards
8 actions
Historical and award details for TAKEDA PHARMACEUTICALS AMERICA, INC.
- Obligations: prior → latest
- $0 → $115K
- Not comparable
- Share: prior → latest
- 0% → 0.060%
- +0.1 percentage points
- All-period obligations
- $115K
- 0.010% of all-period positive obligations · 7 awards
- Recorded activity
- Since Sep 11, 2025
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 7 0 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$105K
0.060%
Dollar movement
−$36K
vs. prior 12 months
Last 12mo awards
2 awards
4 actions
Historical and award details for GLAXOSMITHKLINE, LLC
- Obligations: prior → latest
- $141K → $105K
- −25.6%
- Share: prior → latest
- 0.060% → 0.060%
- 0.0 percentage points
- All-period obligations
- $1.3M
- 0.14% of all-period positive obligations · 69 awards
- Recorded activity
- Since Nov 22, 2021
- through May 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 2 Not reported 1 16 Reported small business 0 0 All-period set-aside types
None reported.
Award activity for Pharmaceutical Preparation Manufacturing at the Department of Justice
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
Base award
This action
+$10.0M
MCKESSON CORPORATION
FMC BUTNER
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 5.5% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $39.7M overall.
- Award net obligations
- $24.4M
- Share of 12-month positive obligations
- 5.5%
Supporting data
- Prime contractor
- #1 · 95.9% share
- $39.7M net decline despite this positive action
- Funding office
- #1 · 18.1% attributed share
- $916K net decline despite this positive action
Modification
This action
+$2.8M
MCKESSON CORPORATION
FMC FORT WORTH
FY26 MCKESSON PHARMACEUTICALS FOR INMATES AT FMC FORT WORTH
Why it stands out
The award grew alongside stronger office-attributed spending.
The modification added $2.8M while office-attributed obligations rose $2.5M overall.
- Award net obligations
- $4.5M
- Share of 12-month positive obligations
- 1.5%
Supporting data
- Prime contractor
- #1 · 95.9% share
- $39.7M net decline despite this positive action
- Funding office
- #3 · 4.5% attributed share
- up 6 ranks · +1.9 percentage points · $2.5M net increase; action exceeded it by $292K
Related:Funding office gain
Modification
This action
+$3.0M
MCKESSON CORPORATION
FMC BUTNER
DELIVERY OF PPV MEDICATIONS TO FCC BUTNER MOD 3-INCREASE FUNDS
Why it stands out
This award grew while spending attributed to its office declined.
The modification added $3.0M while office-attributed obligations fell $916K overall.
- Award net obligations
- $29.2M
- Share of 12-month positive obligations
- 1.6%
Supporting data
- Prime contractor
- #1 · 95.9% share
- $39.7M net decline despite this positive action
- Funding office
- #1 · 18.1% attributed share
- $916K net decline despite this positive action
Base award
This action
+$4.9M
MCKESSON CORPORATION
FCC POLLOCK
PHARMACEUTICALS
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 2.7% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $39.7M overall.
- Award net obligations
- $4.9M
- Share of 12-month positive obligations
- 2.7%
Supporting data
- Prime contractor
- #1 · 95.9% share
- $39.7M net decline despite this positive action
- Funding office
- #2 · 8.9% attributed share
- $6.4M net decline despite this positive action
Base award
This action
+$3.8M
MCKESSON CORPORATION
FCC POLLOCK
PHARMACEUTICALS
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 2.1% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $39.7M overall.
- Award net obligations
- $3.8M
- Share of 12-month positive obligations
- 2.1%
Supporting data
- Prime contractor
- #1 · 95.9% share
- $39.7M net decline despite this positive action
- Funding office
- #2 · 8.9% attributed share
- $6.4M net decline despite this positive action
Base award
This action
+$549K
TAKEDA PHARMACEUTICALS AMERICA, INC.
FMC FORT WORTH
FY26 PHARMACEUTICALS TAKEDA APRIL-SEPTEMBER
Why it stands out
The funding office climbed 6 positions in attributed spending.
It now ranks #3 in attributed spending.
- Award net obligations
- $549K
- Share of 12-month positive obligations
- 0.30%
Supporting data
- Prime contractor
- #2 · 0.97% share
- +0.5 percentage points · $703K net increase; action accounted for 78.1%
View recent award activity by date (10)
- Action+$98KAward net obligations$98K
- Action+$60KAward net obligations$260K
- Action−$50KAward net obligations$111K
- Action−$42KAward net obligations$103K
- Action+$38KAward net obligations$171K
- Action+$30KAward net obligations$57K
- Action+$15KAward net obligations$15K
- Action−$10KAward net obligations$20K
- Action+$5KAward net obligations$5K
- Action+$390Award net obligations$390
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology